From AOL News today:
The benefits from a drug which helps obese people to lose weight “no longer outweigh its risks”, the European Medicines Agency said today.
The agency recommended Acomplia’s marketing licence be suspended after it was told that patients who took the drug doubled their risk of psychiatric disorders.
The Medicines and Healthcare products Regulatory Agency (MHRA), which oversees drugs in the UK, said healthcare professionals should not give any new prescriptions for Acomplia.
Patients who are already taking the drug will have their treatment reviewed and should contact their doctor or pharmacist.
They do not need to stop taking the drug immediately, but can do so if they wish.